{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:09:40Z","timestamp":1790111380337,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejpb.2026.115130","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:41:32Z","timestamp":1780501292000},"page":"115130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based study"],"prefix":"10.1016","volume":"226","author":[{"given":"Yoshinori","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6259-2089","authenticated-orcid":false,"given":"Kazuki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-6287","authenticated-orcid":false,"given":"Atsushi","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115130_b0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2016.04.013","article-title":"Prediction of positive food effect: Bioavailability enhancement of BCS class II drugs","volume":"506","author":"Raman","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12248-021-00664-z","article-title":"Comparison of predictions by BCS, rDCS and Machine Learning for the effect of Food on Oral Drug Absorption based on Features calculated In silico","volume":"24","author":"Hoshino","year":"2022","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2026.115130_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121329","article-title":"Machine learning predicts the effect of food on orally administered medicines","volume":"611","author":"Gavins","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100488","article-title":"Food effects on gastrointestinal physiology and drug absorption","volume":"48","author":"Kambayashi","year":"2023","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2026.115130_b0025","unstructured":"European Medicines Agency, Guidance on the Investigation of Bioequivalence, (2010). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-bioequivalence-rev1_en.pdf (accessed March 8, 2024)."},{"key":"10.1016\/j.ejpb.2026.115130_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100502","article-title":"Evaluation and prediction of oral drug absorption and bioequivalence with food-druginteraction","volume":"50","author":"Tsume","year":"2023","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2026.115130_b0035","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1208\/s12249-018-1159-0","article-title":"Physiological Considerations and In Vitro strategies for evaluating the Influence of Food on Drug Release from Extended-Release Formulations","volume":"19","author":"Koziolek","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115130_b0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cpdd.1385","article-title":"Physiologically based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake timing on Drug Exposure","volume":"13","author":"Nakayama","year":"2024","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ejpb.2026.115130_b0045","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/pharmaceutics15122726","article-title":"Physiologically based Biopharmaceutics Model (PBBM) of Minimally absorbed locally acting drugs in the Gastrointestinal Tract\u2014Case Study: Tenapanor","volume":"15","author":"Stamatopoulos","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115130_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106788","article-title":"Predicting gastric emptying of drug substances taken under postprandial conditions by combination of biorelevant dissolution and mechanistic in silico modeling","volume":"198","author":"Winter","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0055","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/acs.molpharmaceut.1c00778","article-title":"Importance of Gastric Secretion and the Rapid Gastric Emptying of Ingested Water along the Lesser Curvature (\u201cMagenstra\u00dfe\u201d) in predicting the In Vivo Performance of Liquid Oral Dosage Forms in the Fed State using a Modeling and simulation","volume":"19","author":"Kiyota","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acs.molpharmaceut.2c00666","article-title":"Dynamic changes in Gastrointestinal Fluid Characteristics after Food Ingestion are Important for Quantitatively predicting the In Vivo Performance of Oral Solid Dosage Forms in Humans in the Fed State","volume":"20","author":"Kiyota","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0065","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","article-title":"Predicting the impact of physiological and biochemical processes on oral drug bioavailability","volume":"50","author":"Agoram","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115130_b0070","first-page":"9","article-title":"The Simcyp Population based Simulator: Architecture","volume":"1","author":"Jamei","year":"2013","journal-title":"Implementation, and Quality Assurance, in Silico Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115130_b0075","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/acs.molpharmaceut.4c00854","article-title":"Novel use of Manganese Gluconate as a Marker for Visualization of Tablet Dissolution in the Fed Human Stomach using magnetic Resonance Imaging","volume":"22","author":"Akbar","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0080","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1023\/B:PHAM.0000008049.40370.5a","article-title":"Magnetic Resonance Imaging for the in Vivo Evaluation of Gastric-Retentive Tablets","volume":"20","author":"Steingoetter","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115130_b0085","unstructured":"Sawai Pharmaceutical, Tolvaptan OD Tablets 15 mg \u201cSAWAI\u201d \u00ae and Tolvaptan Granules 1% \u201cSAWAI\u201d \u00ae interview form, (2022). https:\/\/www.info.pmda.go.jp\/go\/interview\/1\/300119_2139011D1049_1_021_1F.pdf."},{"key":"10.1016\/j.ejpb.2026.115130_b0090","first-page":"1029","article-title":"Bioequivalence Study of Rivaroxaban OD Tablets 10mg\/15mg \u201cSawai\u201d in healthy Volunteers","volume":"73","author":"Kitagawa","year":"2024","journal-title":"Journal of New Remedies & Clinics"},{"key":"10.1016\/j.ejpb.2026.115130_b0095","unstructured":"Japan Pharmaceuticals Medical Device Agency, Clinical overview for Samsca, (2010). https:\/\/www.pmda.go.jp\/drugs\/2010\/P201000054\/index.html (accessed August 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115130_b0100","unstructured":"Japan Pharmaceuticals Medical Device Agency, Clinical overview for Rivaroxaban OD Tablets [Sawai], (2019). https:\/\/www.info.pmda.go.jp\/go\/interview\/1\/300119_3339003F3051_1_021_1F.pdf (accessed August 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115130_b0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0110","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115130_b0115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/acs.molpharmaceut.7b00919","article-title":"Gastric Emptying and Small Bowel Water Content after Administration of Grapefruit Juice Compared to Water and Isocaloric Solutions of Glucose and Fructose: a Four-Way Crossover MRI pilot Study in healthy Subjects","volume":"15","author":"Grimm","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0120","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1021\/acs.molpharmaceut.7b00623","article-title":"Gastric Water Emptying under Fed State Clinical Trial Conditions is as Fast as under Fasted Conditions","volume":"14","author":"Grimm","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0125","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0130","series-title":"Biopharmaceutics of Orally Administered drugs; chapter 5","author":"Macheras","year":"1995"},{"key":"10.1016\/j.ejpb.2026.115130_b0135","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1023\/A:1010927026837","article-title":"The effect of Polyethylene Glycol 400 on Gastrointestinal Transit: Implications for the Formulation of Poorly-Water Soluble Drugs","volume":"18","author":"Basit","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115130_b0140","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1023\/A:1018911728161","article-title":"Yu, an Integrated Model for determining Causes of Poor Oral Drug Absorption","volume":"16","author":"Lawrence","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115130_b0145","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/dmd.119.086918","article-title":"Systematic Development and Verification of a Physiologically based Pharmacokinetic Model of Rivaroxaban","volume":"47","author":"Cheong","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2026.115130_b0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejpb.2015.05.015","article-title":"Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3","volume":"94","author":"Fuchs","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.113934","article-title":"Estimation of the critical micelle concentration of sodium taurocholate in intestine-relevant conditions using complimentary techniques","volume":"214","author":"Am\u00e9zqueta","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.ejpb.2026.115130_b0160","unstructured":"US Food and Drug Administration, Clinical Review(s) for SAMSCA, (2009). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022275s000_ChemR.pdf (accessed December 8, 2025)."},{"key":"10.1016\/j.ejpb.2026.115130_b0165","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5414\/CP201812","article-title":"The effect of food on the absorption and pharmacokinetics of rivaroxaban","volume":"51","author":"Stampfuss","year":"2013","journal-title":"Int. Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.ejpb.2026.115130_b0170","unstructured":"Japan Pharmaceuticals Medical Device Agency, Clinical overview for Xarelto, (2012). https:\/\/www.pmda.go.jp\/drugs\/2020\/P20201215001\/index.html (accessed August 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115130_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the Human Upper Gastrointestinal Contents under Conditions Simulating Bioavailability\/Bioequivalence Studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115130_b0180","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/mp500022u","article-title":"Intragastric volume changes after Intake of a High-Caloric, High-Fat Standard breakfast in healthy Human Subjects Investigated by MRI","volume":"11","author":"Koziolek","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0185","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpb.2021.04.005","article-title":"Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability","volume":"163","author":"Dahlgren","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jconrel.2005.08.018","article-title":"Impact of the intragastric location of extended release tablets on food interactions","volume":"108","author":"Weitschies","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115130_b0195","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.xphs.2024.01.001","article-title":"Understanding the Conditions under which drugs are Transferred from the Stomach through the Upper Small Intestine after a High-Calorie, High-Fat Meal","volume":"113","author":"Dietrich","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1023\/A:1011098125916","article-title":"Monitoring the Intragastric distribution of a Colloidal Drug Carrier Model by magnetic Resonance Imaging","volume":"18","author":"Faas","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115130_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105351","article-title":"Disposition of two highly permeable drugs in the upper gastrointestinal lumen of healthy adults after a standard high-calorie, high-fat meal","volume":"149","author":"Pentafragka","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpba.2013.05.011","article-title":"Biorelevant solubility of poorly soluble drugs: Rivaroxaban, furosemide, papaverine and niflumic acid","volume":"83","author":"Tak\u00e1cs-Nov\u00e1k","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115130_b0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/pharmaceutics14020415","article-title":"Formulation Approaches for improving the Dissolution Behavior and Bioavailability of Tolvaptan using SMEDDS","volume":"14","author":"Lee","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115130_b0220","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/jps.10158","article-title":"Examination of the Solubilization of drugs by Bile Salt Micelles","volume":"91","author":"Wiedmann","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-food-022811-101214","article-title":"The Structure of the Casein Micelle of Milk and its changes during processing","volume":"3","author":"Dalgleish","year":"2012","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115130_b0230","first-page":"1249","article-title":"Recent Techniques to Improve Amorphous Dispersion Performance with Quality Design","volume":"17","author":"Bhatta","year":"2025","journal-title":"Physicochemical Monitoring, Molecular Simulation, and Machine Learning, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115130_b0235","first-page":"588","article-title":"Is a lower Dose of Rivaroxaban Required for Asians?","volume":"15","author":"Liu","year":"2023","journal-title":"A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban, Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115130_b0240","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1208\/s12248-017-0099-z","article-title":"Incorporation of the Time-Varying Postprandial increase in Splanchnic Blood Flow into a PBPK Model to Predict the effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs","volume":"19","author":"Rose","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2026.115130_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2026.115130_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118937","article-title":"Characterization of the buccal and gastric transit of orally disintegrating tablets in humans using gamma scintigraphy","volume":"576","author":"Kambayashi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0255","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s11095-009-9869-3","article-title":"Gastric Emptying of Pellets under Fasting Conditions: a Mathematical Model","volume":"26","author":"Locatelli","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115130_b0260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2982.2007.01061.x","article-title":"Gastric emptying of a non\u2010digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy","volume":"20","author":"Cassilly","year":"2008","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.ejpb.2026.115130_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/j.1750-3841.2008.00766.x","article-title":"Disintegration of Solid Foods in Human Stomach","volume":"73","author":"Kong","year":"2008","journal-title":"J. Food Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0270","article-title":"Is there a fast track (\u201cDarmstrasse\u201d) for fluids in the small intestine?","volume":"198","author":"Gro\u00dfmann","year":"2024","journal-title":"Evidence from Magnetic Resonance Imaging, European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115130_b0275","doi-asserted-by":"crossref","DOI":"10.5599\/admet.1427","article-title":"Effect of divalent and trivalent metal ions on artificial membrane permeation of fluoroquinolones","author":"Nakatani","year":"2022","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejpb.2026.115130_b0280","doi-asserted-by":"crossref","DOI":"10.5599\/admet.797","article-title":"Permeation characteristics of tetracyclines in parallel artificial membrane permeation assay II: effect of divalent metal ions and mucin","author":"Yamauchi","year":"2020","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejpb.2026.115130_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105535","article-title":"Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditions","volume":"155","author":"Pentafragka","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0290","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14497","article-title":"A novel <scp>MRI<\/scp> \u2010based three\u2010dimensional model of stomach volume, surface area, and geometry in response to gastric filling and emptying","volume":"35","author":"Bertoli","year":"2023","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.ejpb.2026.115130_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114341","article-title":"Drug dissolution and transit in a heterogenous gastric chyme after fed administration: Semi-mechanistic modeling and simulations for an immediate-release and orodispersible tablets containing a poorly soluble drug","volume":"200","author":"Danielak","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115130_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2026.104155","article-title":"A multicompartment stomach physiologically-based pharmacokinetic model capturing gastric reacidification can improve food effect predictions of weak bases","volume":"115","author":"Cheng","year":"2026","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0305","first-page":"1066","article-title":"Bioequivalence Study of Rivaroxaban Tablets 10mg\/15mg \u201cSawai\u201d in healthy Volunteers","volume":"73","author":"Kitagawa","year":"2024","journal-title":"Journal of New Remedies & Clinics"},{"key":"10.1016\/j.ejpb.2026.115130_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2021.110293","article-title":"Mixing and emptying of gastric contents in human-stomach: a numerical study","volume":"118","author":"Li","year":"2021","journal-title":"J. Biomech."},{"key":"10.1016\/j.ejpb.2026.115130_b0315","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1039\/C7FO01226H","article-title":"Investigating mixing and emptying for aqueous liquid content from the stomach using a coupled biomechanical-SPH model","volume":"9","author":"Harrison","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.ejpb.2026.115130_b0320","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2025.0291","article-title":"In silico study of the dynamics of solid food particles in the stomach during gastric digestion","volume":"22","author":"Kuhar","year":"2025","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.ejpb.2026.115130_b0325","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1111\/1750-3841.17157","article-title":"A review of the use of numerical analysis in stomach modeling","volume":"89","author":"Liu","year":"2024","journal-title":"J. Food Sci."},{"key":"10.1016\/j.ejpb.2026.115130_b0330","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/pharmaceutics12060493","article-title":"Intrinsic Dissolution Rate Profiling of Poorly Water-Soluble Compounds in Biorelevant Dissolution Media","volume":"12","author":"Teleki","year":"2020","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:40:27Z","timestamp":1790109627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"alternative-id":["S0939641126001517"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115130","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115130"}}